Aclaris Therapeutics Inc 8AT.DU Stock
1.17 EUR
{{ price }}
0.515457%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
1.17
-
1.17 EUR
VOLUME [24H]
200 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
Aclaris Therapeutics Inc Price Chart
Aclaris Therapeutics Inc 8AT.DU Financial and Trading Overview
| Aclaris Therapeutics Inc stock price | 1.17 EUR |
| Previous Close | 9.1 EUR |
| Open | 8.95 EUR |
| Bid | 8.95 EUR x N/A |
| Ask | 9.15 EUR x N/A |
| Day's Range | 8.95 - 8.95 EUR |
| 52 Week Range | 6.61 - 18.19 EUR |
| Volume | 200 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8AT.DU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Aclaris Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 18.19 EUR |
| 52 Week Low | 6.61 EUR |
| 50-Day Moving Average | 7.84 EUR |
| 200-Day Moving Average | 12.69 EUR |
8AT.DU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Aclaris Therapeutics Inc Stock
What is a current 8AT.DU stock price?
Aclaris Therapeutics Inc 8AT.DU stock price today per share is 1.17 EUR.
How to purchase Aclaris Therapeutics Inc stock?
You can buy 8AT.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aclaris Therapeutics Inc?
The stock symbol or ticker of Aclaris Therapeutics Inc is 8AT.DU.
How many shares does Aclaris Therapeutics Inc have in circulation?
The max supply of Aclaris Therapeutics Inc shares is 0.
What is Aclaris Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
Aclaris Therapeutics Inc PE Ratio is now.
What was Aclaris Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
Aclaris Therapeutics Inc EPS is 0 EUR over the trailing 12 months.